GUTS logo

Fractyl Health, Inc. (GUTS)

Profile

Full Name

Fractyl Health, Inc.

Ticker

NASDAQ: GUTS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 2, 2024

Indexes

Not included

Website

https://fractyl.com

Employees

109

Key Details

Price

$1.02(+4.40%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$93.00K(-22.50% YoY)

Annual EPS

-$1.62(+92.32% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.02
    GUTS price is $1.02

    30-Day Relative Volume

    0.89
    GUTS 30-day relative volume is 0.89

    Price Performance

    Price Most recent change

    +4.4%
    GUTS price was up +4.4% on Aug 15, 2025

    Price YTD change

    -50.49%
    GUTS price is down -50.49% since January 1st

    Price 1-year change

    -56.6%
    GUTS price is down -56.6% year-on-year

    Price 3-year change

    -
    GUTS price 3-year change is unknown

    Price Range

    Price All-time high

    $14.50
    GUTS price is currently -92.97% below its historical high of $14.50

    Price 3-year low

    $0.82
    GUTS price is currently +23.64% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $69.38M
    GUTS market capitalization is $69.38 million

    Market cap 3-year change

    -
    GUTS market capitalization 3-year change is unknown

    Market cap All-time high

    $611.05M
    GUTS market capitalization is currently -88.65% below its historical high of $611.05 million

    Market cap sector rank

    37.73%
    GUTS market capitalization is higher than 37.73% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +41.93%
    GUTS shares outstanding is up +41.93% year-on-year

    Shares Outstanding 3-Year Change

    +42.89%
    GUTS shares outstanding is up +42.89% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.61
    GUTS beta is 0.61

    200-day SMA

    $1.75
    GUTS price is currently -41.74% below its 200-day simple moving average

    50-day SMA

    $1.69
    GUTS price is currently -39.77% below its 50-day simple moving average

    RSI

    29.90
    GUTS 14-day relative strength index is 29.90

    Volume

    0.89
    GUTS 30-day relative volume is 0.89

    ATR

    $0.13
    GUTS average true range is $0.13

    10-day Historical Volatility

    237.03%
    GUTS 10-day historical volatility is 237.03%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $93.00K
    GUTS annual revenue is $93.00 thousand

    Revenue Analysts estimate

    -
    GUTS annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -22.5%
    GUTS annual revenue is down -22.5% year-on-year

    Revenue Sector rank

    31.55%
    GUTS annual revenue is higher than 31.55% of companies in Healthcare sector

    EPS

    EPS

    -$1.62
    GUTS annual earnings per share is -$1.62

    EPS Analysts estimate

    -$1.50
    GUTS annual earnings per share is currently +8.24% higher than the consensus analysts' forecast

    EPS 1-year change

    +92.32%
    GUTS annual earnings per share is up +92.32% year-on-year

    EPS Sector rank

    41.08%
    GUTS annual earnings per share is higher than 41.08% of companies in Healthcare sector

    Profit

    Gross profit

    -$634.00K
    GUTS annual gross profit is -$634.00 thousand

    Gross margin

    -681.72%
    GUTS annual gross profit margin is -681.72%

    Operating profit

    -$93.53M
    GUTS annual operating income is -$93.53 million

    Operating margin

    -100.57K%
    GUTS annual operating profit margin is -100.57 thousand%

    Net income

    -$68.69M
    GUTS annual net profit is -$68.69 million

    Net margin

    -73.86K%
    GUTS annual net profit margin is -73.86 thousand%

    Expenses

    Total expenses

    $93.62M
    GUTS annual total expenses is $93.62 million

    Operating expenses

    $93.57M
    GUTS annual total operating expenses is $93.57 million

    Cost of goods sold

    $727.00K
    GUTS annual cost of goods sold is $727.00 thousand

    Selling, general & administrative expenses

    $23.10M
    GUTS annual SGA is $23.10 million

    Depreciation and amortization

    $677.00K
    GUTS annual depreciation & amortization is $677.00 thousand

    Interest expense

    $0.00
    GUTS annual interest expense is $0.00

    Income tax

    $0.00
    GUTS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$93.53M
    GUTS annual earnings before interest & taxes is -$93.53 million

    EBITDA

    -$92.85M
    GUTS annual EBITDA is -$92.85 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $108.08M
    GUTS annual total assets is $108.08 million

    Non current assets

    $36.31M
    GUTS annual long term assets is $36.31 million

    Current assets

    $71.76M
    GUTS annual total current assets is $71.76 million

    Cash and cash equivalents

    $67.46M
    GUTS annual cash & cash equivalents is $67.46 million

    Accounts receivable

    $0.00
    GUTS annual accounts receivable is $0.00

    Inventory

    $73.00K
    GUTS annual inventory is $73.00 thousand

    Liabilities

    Total liabilities

    $79.65M
    GUTS annual total liabilities is $79.65 million

    Long term liabilities

    $59.88M
    GUTS annual total long term liabilities is $59.88 million

    Current liabilities

    $19.77M
    GUTS annual total current liabilities is $19.77 million

    Accounts payable

    $3.24M
    GUTS annual accounts payable is $3.24 million

    Debt

    Total debt

    $62.50M
    GUTS annual total debt is $62.50 million

    Total debt 1-year change

    -27.65%
    GUTS annual total debt is down -27.65% year-on-year

    Long term debt

    $57.54M
    GUTS annual long term debt is $57.54 million

    Short term debt

    $4.96M
    GUTS annual short term debt is $4.96 million

    Equity & Capital

    Shareholders equity

    $28.42M
    GUTS annual stockholders equity is $28.42 million

    Book value

    $28.42M
    GUTS annual book value is $28.42 million

    Retained earnings

    -$415.31M
    GUTS annual retained earnings is -$415.31 million

    Working capital

    $51.99M
    GUTS annual working capital is $51.99 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$65.52M
    GUTS annual cash flow from operations is -$65.52 million

    Cash from operations 1-year change

    -53%
    GUTS annual cash flow from operations is down -53% year-on-year

    Cash from investing

    -$1.76M
    GUTS annual cash flow from investing activities is -$1.76 million

    Cash from investing 1-year change

    -391.64%
    GUTS annual cash flow from investing activities is down -391.64% year-on-year

    Cash from financing

    $101.23M
    GUTS annual cash flow from financing activities is $101.23 million

    Cash from financing 1-year change

    +268.94%
    GUTS annual cash flow from financing activities is up +268.94% year-on-year

    CAPEX

    CAPEX

    $1.76M
    GUTS annual capital expenditures is $1.76 million

    CAPEX 1-year change

    +391.64%
    GUTS annual capital expenditures is up +391.64% year-on-year

    Free Cash Flow

    Free cash flow

    -$67.29M
    GUTS annual free cash flow is -$67.29 million

    Free cash flow 1-year change

    -55.82%
    GUTS annual free cash flow is down -55.82% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -681.72%
    GUTS annual gross profit margin is -681.72%

    Operating margin

    -100.57K%
    GUTS annual operating profit margin is -100.57 thousand%

    Net margin

    -73.86K%
    GUTS annual net profit margin is -73.86 thousand%

    ROA & ROE

    ROA

    -74.55%
    GUTS annual return on assets is -74.55%

    ROE

    -241.68%
    GUTS annual return on equity is -241.68%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    GUTS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    GUTS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -3.81
    GUTS price to book ratio is -3.81

    PB ratio Sector rank

    7.01%
    GUTS price to book ratio is higher than 7.01% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4081.46
    GUTS price to sales ratio is 4081.46

    PS ratio Sector rank

    99.38%
    GUTS price to sales ratio is higher than 99.38% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $47.09M
    GUTS enterprise value is $47.09 million

    Enterprise value Sector rank

    35.14%
    GUTS enterprise value is higher than 35.14% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.48
    GUTS EV/EBITDA is -0.48

    EV/EBITDA Sector rank

    54.8%
    GUTS EV/EBITDA is higher than 54.8% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.63
    GUTS annual current ratio is 3.63

    Quick ratio

    3.63
    GUTS annual quick ratio is 3.63

    Leverage

    Debt to equity

    2.20
    GUTS annual debt to equity ratio is 2.20

    Interest coverage ratio

    -
    GUTS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    GUTS piotroski f-score value is unknown

    Altman Z-Score

    -7.13
    GUTS altman z-score is -7.13

    Analyst ratings

    Recent major analysts updates

    Aug 14, 25 Canaccord Genuity
    Buy
    Apr 15, 25 Canaccord Genuity
    Buy
    Feb 3, 25 Morgan Stanley
    Overweight
    Feb 28, 24 Evercore ISI Group
    Outperform
    Feb 27, 24 Morgan Stanley
    Overweight

    Institutional Ownership

    Screeners with GUTS included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Earnings this week
    • What is the ticker symbol for Fractyl Health, Inc.?
    • Does Fractyl Health, Inc. pay dividends?
    • What sector is Fractyl Health, Inc. in?
    • What industry is Fractyl Health, Inc. in?
    • What country is Fractyl Health, Inc. based in?
    • When did Fractyl Health, Inc. go public?
    • Is Fractyl Health, Inc. in the S&P 500?
    • Is Fractyl Health, Inc. in the NASDAQ 100?
    • Is Fractyl Health, Inc. in the Dow Jones?
    • When was Fractyl Health, Inc.'s last earnings report?
    • When does Fractyl Health, Inc. report earnings?

    What is the ticker symbol for Fractyl Health, Inc.?

    The ticker symbol for Fractyl Health, Inc. is NASDAQ:GUTS

    Does Fractyl Health, Inc. pay dividends?

    No, Fractyl Health, Inc. does not pay dividends

    What sector is Fractyl Health, Inc. in?

    Fractyl Health, Inc. is in the Healthcare sector

    What industry is Fractyl Health, Inc. in?

    Fractyl Health, Inc. is in the Biotechnology industry

    What country is Fractyl Health, Inc. based in?

    Fractyl Health, Inc. is headquartered in United States

    When did Fractyl Health, Inc. go public?

    Fractyl Health, Inc.'s initial public offering (IPO) was on February 2, 2024

    Is Fractyl Health, Inc. in the S&P 500?

    No, Fractyl Health, Inc. is not included in the S&P 500 index

    Is Fractyl Health, Inc. in the NASDAQ 100?

    No, Fractyl Health, Inc. is not included in the NASDAQ 100 index

    Is Fractyl Health, Inc. in the Dow Jones?

    No, Fractyl Health, Inc. is not included in the Dow Jones index

    When was Fractyl Health, Inc.'s last earnings report?

    Fractyl Health, Inc.'s most recent earnings report was on August 12, 2025

    When does Fractyl Health, Inc. report earnings?

    The next expected earnings date for Fractyl Health, Inc. is November 11, 2025
    On this page